- Home
- GVH vs XAIR Comparison
GVH vs XAIR Comparison
Compare GVH & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GVH | XAIR |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6M | 3.0M |
| IPO Year | 2023 | 2015 |
Fundamental Metrics
Financial Performance| Metric | GVH | XAIR |
|---|---|---|
| Price | $0.92 | $2.24 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 24.8K | ★ 27.6K |
| Earning Date | 07-14-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,679,000.00 |
| Revenue This Year | $1.85 | $4.23 |
| Revenue Next Year | N/A | $108.84 |
| P/E Ratio | $0.74 | ★ N/A |
| Revenue Growth | N/A | ★ 107.26 |
| 52 Week Low | $0.77 | $0.33 |
| 52 Week High | $6.46 | $8.19 |
Technical Indicators
Market Signals| Indicator | GVH | XAIR |
|---|---|---|
| Relative Strength Index (RSI) | 43.57 | 41.37 |
| Support Level | $0.87 | $2.05 |
| Resistance Level | $1.13 | $3.30 |
| Average True Range (ATR) | 0.07 | 0.16 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 46.95 | 52.63 |
Price Performance
Historical ComparisonAbout GVH Globavend Holdings Limited
Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.
About XAIR Beyond Air Inc.
Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.